Search Results - "Yuki, S"

Admp regulates tail bending by controlling ventral epidermal cell polarity via phosphorylated myosin localization in Ciona by Kogure, Yuki S, Muraoka, Hiromochi, Koizumi, Wataru C, Gelin-Alessi, Raphaël, Godard, Benoit, Oka, Kotaro, Heisenberg, Carl-Philipp, Hotta, Kohji

“…Ventral tail bending, which is transient but pronounced, is found in many chordate embryos and constitutes an interesting model of how tissue interactions…”
Get full text

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial by Yamada, Y., Denda, T., Gamoh, M., Iwanaga, I., Yuki, S., Shimodaira, H., Nakamura, M., Yamaguchi, T., Ohori, H., Kobayashi, K., Tsuda, M., Kobayashi, Y., Miyamoto, Y., Kotake, M., Shimada, K., Sato, A., Morita, S., Takahashi, S., Komatsu, Y., Ishioka, C.

“…Combination therapy with oral fluoropyrimidine and irinotecan has not yet been established as first-line treatment of metastatic colorectal cancer (mCRC). We…”
Get full text

Histone H3.3 variant plays a critical role on zygote-to-oocyst development in malaria parasites by Tateishi, Yuki S., Araki, Tamasa, Kawai, Satoru, Koide, Shuhei, Umeki, Yuko, Imai, Takashi, Saito-Nakano, Yumiko, Kikuchi, Masaki, Iwama, Atsushi, Hisaeda, Hajime, Coban, Cevayir, Annoura, Takeshi

“…The Plasmodium life cycle involves differentiation into multiple morphologically distinct forms, a process regulated by developmental stage-specific gene…”
Get full text

Retrospective analysis of the efficacy and safety of regorafenib in patients with advanced GIST by Nakatsumi, H., Komatsu, Y., Saito, R., Ito, K., Nakano, S., Kawamoto, Y., Yuki, S., Sakamoto, N.

Get full text

Congenital self‐healing reticulohistiocytosis: An atypical presentation acquired in a 10‐month‐old by Yuki, Christopher S., Young, Patrick J., Ohsie, Steven, Nguyen, Xuan

“…Congenital self‐healing reticulohistiocytosis of Hashimoto and Pritzker (CSHR) is a rare, benign form of Langerhans Cell Histiocytosis (LCH) that presents at…”
Get full text

VOLTAGE: Investigator-initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer by Yoshino, T., Bando, H., Tsukada, Y., Inamori, K., Yuki, S., Komatsu, Y., Homma, S., Uemura, M., Kato, T., Kotani, D., Fukuoka, S., Sasaki, T., Nishizawa, Y., Nakamura, N., Wakabayashi, M., Kojima, M., Togashi, Y., Sato, A., Nishikawa, H., Ito, M.

Get full text

The comparison between UGT1A1 single heterozygous and wild-type regarding the clinical outcomes of fixed-dose irinotecan monotherapy for advanced gastric cancer: a multicenter retrospective study by Ando, T., Nakano, S., Yuki, S., Sawada, K., Muranaka, T., Kawamoto, Y., Nakatsumi, H., Yoshita, H., Harada, K., Kobayashi, Y., Miyagishima, T., Hatanaka, K., Tanimoto, A., Ishiguro, A., Honda, T., Sasaki, T., Dazai, M., Komatsu, Y.

Get full text

A retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: analysis of Glasgow prognostic score (GPS) by Harada, K., Nakano, S., Yuki, S., Sawada, K., Muranaka, T., Kawamoto, Y., Nakatsumi, H., Yoshita, H., Ando, T., Kobayashi, Y., Miyagishima, T., Hatanaka, K., Tanimoto, A., Ishiguro, A., Honda, T., Dazai, M., Sasaki, T., Komatsu, Y.

Get full text

A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602) by Nakamura, M., Muranaka, T., Yagisawa, M., Kawamoto, Y., Yuki, S., Ishiguro, A., Dazai, M., Sogabe, S., Harada, K., Kobayashi, Y., Miyagishima, T., Okamura, N., Tsuji, Y., Terae, S., Ono, K., Komatsu, Y.

Get full text

The prospective multicenter study of relation between 5-HIAA/substance P plasma concentration transition and nausea/vomiting in patients with gastrointestinal cancer receiving moderately emetogenic chemotherapy (MEC) by Sawada, K., Komatsu, Y., Muranaka, T., Nakano, S., Kawamoto, Y., Nakatsumi, H., Yuki, S., Dazai, M., Saiki, T., Ishiguro, A., Tateyama, M., Ono, K., Ohnishi, S., Sakamoto, N.

Get full text

P-168Retrospective comparison of efficacy and safety of docetaxel and weekly-paclitaxel as 2nd-line chemotherapy for patients with unresectable or recurrent esophageal cancer by Nakatsumi, H, Komatsu, Y, Sawada, K, Muranaka, T, Kawamoto, Y, Yuki, S, Sakamoto, N

Get full text

Updated analysis of a phase II study of SOX plus trastuzumab for the patients with HER2 positive advanced or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS1501B by Yuki, S., Shinozaki, K., Kashiwada, T., Kusumoto, T., Iwatsuki, M., Satake, H., Tokunaga, S., Emi, Y., Makiyama, A., Kawamoto, Y., Komatsu, Y., Shimokawa, M., Saeki, H., Oki, E., Baba, H., Maehara, Y.

Get full text

The prospective multicenter study of relation between 5-HIAA/substance P plasma concentration transition and nausea/vomiting in patients with gastrointestinal cancer receiving moderately emetogenic chemotherapy by Muranaka, T., Komatsu, Y., Ohnishi, S., Yagisawa, M., Sawada, K., Kawamoto, Y., Nakatsumi, H., Yuki, S., Dazai, M., Saiki, T., Ishiguro, A., Tateyama, M., Ono, K., Sakamoto, N.

Get full text

HGCSG 1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancer by Ishiguro, A., Kawamoto, Y., Yuki, S., Nakano, S., Yagisawa, M., Sawada, K., Muranaka, T., Hayashi, H., Nakatsumi, H., Saiki, T., Harada, K., Kobayashi, Y., Iwanaga, I., Hatanaka, K., Sakata, Y., Komatsu, Y.

Get full text

Multicenter phase 2 trial of weekly 5-FU plus l-LV regimen as salvage line chemotherapy for oral fluorouracil-resistant advanced gastric cancer (HGCSG1502) by Ueda, A., Muranaka, T., Kawamoto, Y., Sawada, K., Nakatsumi, H., Harada, K., Kobayashi, Y., Miyagishima, T., Hatanaka, K., Dazai, M., Kawahata, S., Sasaki, T., Sasaki, Y., Kato, S., Shinada, K., Tsuji, Y., Yuki, S., Sakamoto, N., Nishimoto, N., Sakata, Y., Komatsu, Y.

Get full text

North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer: final analysis (NORTH/HGCSG1003) by Ishiguro, A., Yuki, S., Takahashi, N., Shichinohe, T., Nakatsumi, H., Kawamoto, Y., Kusumi, T., Harada, K., Iwanaga, I., Hatanaka, K., Oomori, K., Nakamura, M., Senmaru, N., Iwai, K., Koike, M., Sakamoto, N., Taketomi, A., Hirano, S., Ito, Y.M., Komatsu, Y.

Get full text

HGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer by Yoshikawa, A., Kawamoto, Y., Yuki, S., Nakano, S., Sawada, K., Muranaka, T., Nakatsumi, H., Harada, K., Kobayashi, Y., Miyagishima, T., Saiki, T., Ishiguro, A., Saito, R., Ehira, N., Iwanaga, I., Hatanaka, K., Abe, N., Sakamoto, N., Sakata, Y., Komatsu, Y.

Get full text

A feasibility study of edoxaban for the cancer-associated asymptomatic venous thromboembolism in Japanese gastrointestinal cancer patients receiving chemotherapy (ExCAVE study) by Nakamura, M., Yagisawa, M., Saiki, T., Ishiguro, A., Sawada, K., Yuki, S., Sasaki, T., Ando, T., Ohori, H., Kotaka, M., Muto, O., Shindo, Y., Nakashima, K., Hosokawa, A., Doi, A., Izawa, N., Sunakawa, Y., Satoh, A., Ono, K., Komatsu, Y.

Get full text

HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index by Suzuki, K., Yuki, S., Nakano, S., Kawamoto, Y., Nakatsumi, H., Hatanaka, K., Ando, T., Furukawa, K., Ishiguro, A., Ohta, T., Eto, K., Nakajima, J., Nakamura, M., Sogabe, S., Kato, K., Tateyama, M., Kato, S., Sekiguchi, M., Sakata, Y., Komatsu, Y.

Get full text

HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of cases of prior regorafenib by Tsuji, Y., Yuki, S., Sawada, K., Muranaka, T., Kobayashi, Y., Okuda, H., Ogawa, K., Minami, S., Honda, T., Dazai, M., Kato, T., Sasaki, T., Shindo, Y., Ota, S., Sato, A., Ueda, A., Saitoh, S., Nagai, H., Sakata, Y., Komatsu, Y.

Get full text